ATE491434T1 - Augentropfen enthaltend ketotifen - Google Patents

Augentropfen enthaltend ketotifen

Info

Publication number
ATE491434T1
ATE491434T1 AT01124282T AT01124282T ATE491434T1 AT E491434 T1 ATE491434 T1 AT E491434T1 AT 01124282 T AT01124282 T AT 01124282T AT 01124282 T AT01124282 T AT 01124282T AT E491434 T1 ATE491434 T1 AT E491434T1
Authority
AT
Austria
Prior art keywords
ketotifene
eye drops
drops containing
ketotifen
present
Prior art date
Application number
AT01124282T
Other languages
English (en)
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8235893&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE491434(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Pharma Gmbh filed Critical Novartis Pharma Gmbh
Application granted granted Critical
Publication of ATE491434T1 publication Critical patent/ATE491434T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01124282T 1998-01-15 1999-01-13 Augentropfen enthaltend ketotifen ATE491434T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98810016A EP0938896A1 (de) 1998-01-15 1998-01-15 In Autoklaven behandelbare pharmazeutische Zusammensetzungen mit Komplexbildner

Publications (1)

Publication Number Publication Date
ATE491434T1 true ATE491434T1 (de) 2011-01-15

Family

ID=8235893

Family Applications (2)

Application Number Title Priority Date Filing Date
AT99906123T ATE238036T1 (de) 1998-01-15 1999-01-13 Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner
AT01124282T ATE491434T1 (de) 1998-01-15 1999-01-13 Augentropfen enthaltend ketotifen

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT99906123T ATE238036T1 (de) 1998-01-15 1999-01-13 Autoklavierbare pharmazeutische zusammensetzungen mit komplexbildner

Country Status (12)

Country Link
US (2) US6468548B1 (de)
EP (4) EP0938896A1 (de)
JP (2) JP5442919B2 (de)
AT (2) ATE238036T1 (de)
AU (1) AU742920B2 (de)
CA (1) CA2315767C (de)
CY (1) CY1111126T1 (de)
DE (2) DE69907137T2 (de)
DK (2) DK1172098T3 (de)
ES (2) ES2356229T3 (de)
PT (2) PT1172098E (de)
WO (1) WO1999036055A1 (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775832B2 (en) * 1998-01-15 2004-08-19 Novartis Ag Ophthalmic composition
EP1109581A1 (de) * 1998-09-02 2001-06-27 Allergan Sales, Inc. Geschützte cyclodextrin-enthaltende zusammensetzungen
US6777429B1 (en) * 1999-07-23 2004-08-17 Novartis Ag Ophthalmic composition
JP2001158750A (ja) * 1999-12-02 2001-06-12 Lion Corp 眼科用組成物及び抗アレルギー薬の持続性向上方法
TR200301738T4 (tr) * 2000-01-20 2004-01-21 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Diklofenamid süspansiyon jeli
US6685917B2 (en) * 2000-11-22 2004-02-03 Rxkinetix, Inc. Treatment of mucositis
US20040214797A1 (en) * 2001-05-07 2004-10-28 Allergan, Inc. Preserved pharmaceutical compositions comprising cyclodextrins
AU2002345015A1 (en) * 2001-06-08 2002-12-23 Novartis Pharma Gmbh Ophthalmic once-a-day composition
AR034372A1 (es) * 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
ES2383003T3 (es) * 2001-11-21 2012-06-15 Carl Zeiss Meditec Sas Composición para estabilizar ácido hialurónico
DE10262084B4 (de) * 2002-05-17 2009-12-24 Dr. Franz Köhler Chemie GmbH Protektive Lösung zur Verhinderung von Ischämieschäden
LT1585548T (lt) * 2002-12-09 2018-09-25 Abraxis Bioscience, Llc Farmakologinių agentų kompozicijos ir įvedimo būdai
EP1454636A1 (de) * 2003-03-04 2004-09-08 Dompé S.P.A. Sterilisierung von Glucocorticoid-Arzneimittelteilchen zur Anwendung in der Lunge
US6933289B2 (en) * 2003-07-01 2005-08-23 Allergan, Inc. Inhibition of irritating side effects associated with use of a topical ophthalmic medication
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US20050234018A1 (en) * 2004-04-15 2005-10-20 Allergan, Inc. Drug delivery to the back of the eye
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
US20070208058A1 (en) * 2004-10-25 2007-09-06 Bryant Roy W Stable Pharmaceutical Compositions and Methods of Making and Using Same
BRPI0517451A (pt) * 2004-10-25 2008-10-07 Bausch & Lomb composição oftámilca, e, métodos de tratar conjutivite alérgica e doença de olho seco
US20060089384A1 (en) * 2004-10-25 2006-04-27 Minno George E Ophthalmic compositions and methods of using the same
US20060094700A1 (en) * 2004-11-02 2006-05-04 Allergan, Inc. Heat sterilization of a steroid in the presence of phosphate
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
US7178703B2 (en) 2004-11-23 2007-02-20 Allergan, Inc. Autoclaveable small-volume dropper bottle
US20060186005A1 (en) * 2005-02-24 2006-08-24 Sina Ebnesajjad Terminally sterilizing pharmaceutical package
US20060243696A1 (en) * 2005-04-27 2006-11-02 Spada Lon T Tip design for reducing capillary leakage and water loss for plastic container closures
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
DK1965787T3 (da) * 2005-11-30 2013-06-03 Endo Pharmaceuticals Inc Behandling af xerostomi med en svovlindeholdende antioxidant
KR20150017002A (ko) * 2006-03-17 2015-02-13 존슨 앤드 존슨 비젼 케어, 인코포레이티드 산화에 불안정한 성분을 포함하는 안정화된 눈용 조성물
US20070238789A1 (en) * 2006-03-31 2007-10-11 Chin-Ming Chang Prednisolone acetate compositions
EP2079439B1 (de) * 2006-09-29 2017-01-18 Johnson & Johnson Vision Care, Inc. Verfahren und ophthalmische vorrichtungen zur verwendung bei der behandlung von augenallergien
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
US20090005362A1 (en) * 2007-06-26 2009-01-01 Vo Toan P Compositions Comprising Antihistamines or Mast Cell Stabilizers, and Methods of Making and Using Same
JP5460996B2 (ja) * 2007-10-19 2014-04-02 大正製薬株式会社 眼科用剤
MD3975C2 (ro) * 2007-11-07 2010-06-30 Технический университет Молдовы Sistem de orientare a instalaţiei solare paraboloidale (variante)
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
US8741930B2 (en) * 2008-10-24 2014-06-03 Bridge Pharma, Inc. Treating xerophthalmia with norketotifen
US8765787B2 (en) * 2008-11-21 2014-07-01 Bridge Pharma, Inc. Methods of treatment of xerophthalmia with self-preserving ocular formulations of norketotifen
JP6462201B2 (ja) * 2012-06-14 2019-01-30 ロート製薬株式会社 水性眼科組成物
ITMI20122002A1 (it) * 2012-11-26 2014-05-27 Farmacologico Milanese Srl Lab Preparazioni farmaceutiche liquide stabilizzate
US10174006B2 (en) 2013-06-06 2019-01-08 Novartis Ag Topical aqueous ophthalmic compositions containing a 1H-indole-1-carboxamide derivative and use thereof for treatment of ophthalmic disease
MY179951A (en) 2014-01-10 2020-11-19 Santen Pharmaceutical Co Ltd Pharmaceutical composition containing pyridylaminoacetic acid compound
MA39767B1 (fr) * 2014-05-07 2019-10-31 Croma Pharma Ges M B H Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'œil sec
GB201419540D0 (en) * 2014-11-03 2014-12-17 Nanomerics Ltd Delivery of drugs
US9694003B2 (en) 2015-10-15 2017-07-04 Bridge Pharma, Inc. Formulations and methods for treating high intraocular pressure
CN106109407A (zh) * 2016-08-25 2016-11-16 安徽环球药业股份有限公司 盐酸安妥沙星氯化钠注射液的配制方法
KR20240036731A (ko) 2016-11-29 2024-03-20 오쿨리스 오퍼레이션즈 에스에이알엘 안과용 활성 약학 성분 전달을 위한 고형 사이클로덱스트린 복합체의 제조
CN109833294B (zh) * 2019-04-19 2020-06-09 江苏远恒药业有限公司 一种盐酸洛美沙星滴眼液及其制备工艺
WO2021236671A1 (en) * 2020-05-18 2021-11-25 Vyluma Inc. Low-dose carbachol compositions and methods for treatment of night vision disturbance

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1399834A (en) * 1971-05-12 1975-07-02 Fisons Ltd Pharmaceutical compositions
JPS5428810A (en) * 1977-08-01 1979-03-03 American Home Prod Pharmaceutical composition for eye disease containing 1*33dioxoo1hhbenzo *d * e* isoquinolinee2*3h**acetic acid
JPS62277323A (ja) * 1986-02-19 1987-12-02 Sankyo Co Ltd フマル酸ケトチフエン含有点眼液の製法
US5032392A (en) * 1986-09-04 1991-07-16 Vision Pharmaceuticals Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes
US5165918A (en) * 1988-06-28 1992-11-24 Ciba-Geigy Corporation Antimicrobial ophthalmic solutions containing dodecyl-dimethyl-(2 phenoxyethyl)-ammonium bromide and methods of using the same
CA2044878C (en) * 1990-08-07 2000-12-26 Tacey X. Viegas Thermally reversible and irreversible gels
EP0492902A1 (de) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituierte Pyridine zur Anwendung in der Behandlung von Glaukoma
EP0492904A1 (de) * 1990-12-21 1992-07-01 MERCK SHARP & DOHME LTD. Substituierte Benzol-Derivate zur Anwendung in der Behandlung von Glaukom
US5182102A (en) * 1991-07-12 1993-01-26 Alcon Laboratories, Inc. Anti-glaucoma compositions
AU666957B2 (en) * 1992-08-28 1996-02-29 Alcon Laboratories, Inc. Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
US5624893A (en) * 1993-10-14 1997-04-29 Alcon Laboratories, Inc. Pharmaceutical compositions and methods of treatment of the cornea following laser irradiation
JP3597239B2 (ja) * 1994-03-31 2004-12-02 ライオン株式会社 安定な点眼剤
JPH07324034A (ja) * 1994-05-30 1995-12-12 Toa Yakuhin Kk フマル酸ケトチフェン含有の点眼剤
JP3055753B2 (ja) * 1994-07-05 2000-06-26 昭和薬品化工株式会社 フマル酸ケトチフェン含有点眼液
US5576311A (en) * 1994-11-30 1996-11-19 Pharmos Corporation Cyclodextrins as suspending agents for pharmaceutical suspensions
US5683993A (en) * 1995-06-22 1997-11-04 Ciba Vision Corporation Compositions and methods for stabilizing polymers
FR2738149B1 (fr) * 1995-09-06 1997-11-14 Chauvin Lab Sa Collyre a base d'indometacine pret a l'emploi
JPH09301873A (ja) * 1996-05-13 1997-11-25 Senju Pharmaceut Co Ltd サルファ剤の可溶化方法及びサルファ剤を可溶化させた水性薬剤
US6180093B1 (en) * 1996-09-20 2001-01-30 Bausch & Lomb Incorporated Method and composition for rewetting contact lenses and relieving eye dryness
PL194914B1 (pl) * 1998-04-02 2007-07-31 Novartis Ag Sposób stabilizacji kompozycji farmaceutycznej i zastosowanie przeciwutleniacza wprowadzonego do materiału polimerowego do stabilizacji kompozycji farmaceutycznej
US6395756B2 (en) * 1999-12-23 2002-05-28 Novartis Ag Use of ophthalmic agent

Also Published As

Publication number Publication date
US6468548B1 (en) 2002-10-22
JP2011168601A (ja) 2011-09-01
ES2198127T3 (es) 2004-01-16
DE69907137D1 (de) 2003-05-28
EP2281554A1 (de) 2011-02-09
JP5442919B2 (ja) 2014-03-19
ATE238036T1 (de) 2003-05-15
EP1172098A1 (de) 2002-01-16
EP1172098B1 (de) 2010-12-15
ES2356229T3 (es) 2011-04-06
EP1047406A1 (de) 2000-11-02
DE69943051D1 (de) 2011-01-27
EP0938896A1 (de) 1999-09-01
AU742920B2 (en) 2002-01-17
EP1047406B1 (de) 2003-04-23
PT1047406E (pt) 2003-08-29
DE69907137T2 (de) 2003-11-27
CA2315767A1 (en) 1999-07-22
US20020165254A1 (en) 2002-11-07
CA2315767C (en) 2008-10-28
JP2002509101A (ja) 2002-03-26
DK1047406T3 (da) 2003-07-21
PT1172098E (pt) 2011-02-01
AU2616999A (en) 1999-08-02
WO1999036055A1 (en) 1999-07-22
JP5587237B2 (ja) 2014-09-10
CY1111126T1 (el) 2015-06-11
US6776982B2 (en) 2004-08-17
DK1172098T3 (da) 2011-03-14

Similar Documents

Publication Publication Date Title
ATE491434T1 (de) Augentropfen enthaltend ketotifen
PT842934E (pt) Agonistas de 5-ht1f
TW200606483A (en) Methods for rotationally stabilizing contact lenses
GT200300040A (es) Composicion de ziprasidona y controles sinteticos
ES2194960T3 (es) N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f.
HK1048662A1 (en) Hybrid refractive birefringent multifocal ophthalmic lenses
DK0639577T3 (da) Phosphonooxymethyl- eller methylthiomethylestere af taxanderivater som antitumormidler
DE60239931D1 (de) Kombinationstherapie
DK1051206T3 (da) En multi-formet medicinsk anordning af kollagenbaseret biomateriale
ATE267566T1 (de) Hornhautlinse
ATE254458T1 (de) Antibiotische zusammensetzungen zur behandlung des auges
MXPA03008728A (es) Composicion limpiadora que incluye un blanqueador y para utilizarse en superficies duras.
BR0214230A (pt) Compostos e processos de fabricação de compostos
ATE271390T1 (de) Verwendung von azithromycin zur topischen behandlung von augeninfektionen
NO20003786D0 (no) Oftalmisk sammensetning
DK1198225T3 (da) Epothilonsammensætninger
DE60235474D1 (de) Zusammensetzung für optisches material
DE60200302D1 (de) Laseraugenbehandlungseinrichtung
SE9904404L (sv) Ny komposition
NO20002408D0 (no) 5-HT1F antagonister
DE60211547D1 (de) Für flaschenverpackungsstrassen bestimmte maschine zur automatischen abgabe von schutz-trenn-teilern für flaschengruppen
TW200500350A (en) Photochromic oxazine compounds and methods for their manufacture
BR0210678A (pt) Carbamatos de 2-heterocìclicos-1,2-etanodióis
ES1049629Y (es) Un protector ocular.
IT1303825B1 (it) Corredo di strumenti per microchirurgia oftalmica.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1172098

Country of ref document: EP